ERCC1 and head and neck squamous cell carcinoma: Martens-de Kemp and coworkers from the laboratory of Dr. Brakenhoff recently published that the CDDP-DNA adduct level is the most important determinant of cisplatin sensitivity in HNSCC cells, which does not correlate with the gene expression of ERCC1 [50].